CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 279 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,534,361 | +704.6% | 25,130 | +1085.9% | 0.06% | +326.7% |
| Q1 2022 | $315,000 | +38.2% | 2,119 | +27.6% | 0.02% | -21.1% |
| Q2 2021 | $228,000 | -58.8% | 1,661 | -66.4% | 0.02% | -67.8% |
| Q4 2020 | $554,000 | +0.5% | 4,942 | -35.4% | 0.06% | +55.3% |
| Q2 2020 | $551,000 | -56.8% | 7,647 | -65.7% | 0.04% | -59.1% |
| Q1 2020 | $1,276,000 | +129.9% | 22,280 | +349.0% | 0.09% | +181.8% |
| Q4 2019 | $555,000 | -2.8% | 4,962 | -27.7% | 0.03% | -19.5% |
| Q1 2019 | $571,000 | +149.3% | 6,860 | +137.4% | 0.04% | +141.2% |
| Q3 2018 | $229,000 | -41.0% | 2,890 | -62.0% | 0.02% | -60.5% |
| Q4 2017 | $388,000 | -48.3% | 7,610 | -55.0% | 0.04% | -55.2% |
| Q1 2017 | $751,000 | +147.9% | 16,900 | +134.3% | 0.10% | +166.7% |
| Q1 2016 | $303,000 | -27.5% | 7,213 | -24.1% | 0.04% | -2.7% |
| Q4 2015 | $418,000 | +32.7% | 9,500 | +43.9% | 0.04% | +37.0% |
| Q3 2015 | $315,000 | – | 6,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
| Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
| EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
| Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
| MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
| Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
| OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
| WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
| EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |